纳米技术增强的光动力疗法 (PDT) 和免疫疗法正在成为令人兴奋的癌症治疗方法，在改善患者治疗效果方面具有巨大潜力。通过结合这些方法，在临床前研究中观察到了协同效应，从而增强了对癌症的免疫反应以及克服免疫抑制性肿瘤微环境（TME）的能力。尽管存在解决治疗局限性和制定个性化癌症治疗策略等挑战，但纳米技术支持的 PDT 和免疫疗法以及先进光敏剂 (PS) 的整合代表了癌症治疗中令人兴奋的新途径。研究人员、临床医生和监管机构之间的持续研究、开发和合作对于这些有前途的疗法的进一步发展和成功实施至关重要，最终使全世界的癌症患者受益。版权所有 © 2023 Jia, Wu, Long, Yu, He, Zhu,王、叶、田。

Nanotechnology-enhanced photodynamic therapy (PDT) and immunotherapy are emerging as exciting cancer therapeutic methods with significant potential for improving patient outcomes. By combining these approaches, synergistic effects have been observed in preclinical studies, resulting in enhanced immune responses to cancer and the capacity to conquer the immunosuppressive tumor microenvironment (TME). Despite challenges such as addressing treatment limitations and developing personalized cancer treatment strategies, the integration of nanotechnology-enabled PDT and immunotherapy, along with advanced photosensitizers (PSs), represents an exciting new avenue in cancer treatment. Continued research, development, and collaboration among researchers, clinicians, and regulatory agencies are crucial for further advancements and the successful implementation of these promising therapies, ultimately benefiting cancer patients worldwide.Copyright © 2023 Jia, Wu, Long, Yu, He, Zhang, Wang, Ye and Tian.